Unknown

Dataset Information

0

Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.


ABSTRACT: Two critical concerns in clinical cord blood transplantation are the initial time to engraftment and the subsequent restoration of immune function. These studies measured the impact of progenitor cell dose on both the pace and strength of hematopoietic reconstitution by transplanting nonobese diabetic/severe combined immunodeficiency/interleukin-2 receptor-gamma-null (NS?) mice with lineage-depleted aldehyde dehydrogenase-bright CD34(+) human cord blood progenitors. The progress of each transplant was monitored over an extended time course by repeatedly analyzing the peripheral blood for human hematopoietic cells. In vivo human hematopoietic development was complete. After long-term transplantation assays (? 19 weeks), human T-cell development was documented within multiple tissues in 16 of 32 NS? mice. Human T-cell differentiation was active within NS? thymuses, as documented by the presence of CD4(+) CD8(+) T-cell progenitors as well as T-cell receptor excision circles. It is important to note that although myeloid and B-cell engraftment was detected as early as 4 weeks after transplantation, human T-cell development was exclusively late onset. High progenitor cell doses were associated with a robust human hematopoietic chimerism that accelerated both initial time to engraftment and subsequent T-cell development. At lower progenitor cell doses, the chimerism was weak and the human hematopoietic lineage development was frequently incomplete.

SUBMITTER: Liu C 

PROVIDER: S-EPMC3031401 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.

Liu Congxiao C   Chen Benny J BJ   Deoliveira Divinomar D   Sempowski Gregory D GD   Chao Nelson J NJ   Storms Robert W RW  

Blood 20100910 25


Two critical concerns in clinical cord blood transplantation are the initial time to engraftment and the subsequent restoration of immune function. These studies measured the impact of progenitor cell dose on both the pace and strength of hematopoietic reconstitution by transplanting nonobese diabetic/severe combined immunodeficiency/interleukin-2 receptor-gamma-null (NSγ) mice with lineage-depleted aldehyde dehydrogenase-bright CD34(+) human cord blood progenitors. The progress of each transpla  ...[more]

Similar Datasets

| S-EPMC5746387 | biostudies-literature
| S-EPMC3932655 | biostudies-other
| S-EPMC7448600 | biostudies-literature
| S-EPMC6045964 | biostudies-literature
| S-EPMC5460100 | biostudies-literature
| S-EPMC6745168 | biostudies-literature
| S-EPMC4424412 | biostudies-literature
| S-EPMC5179334 | biostudies-literature
| S-EPMC4756107 | biostudies-literature
| S-EPMC6145177 | biostudies-literature